Cell Biology
Experimental Therapeutic Treatment for Deadly Tick-Borne Virus
Findings of the treatment of Bourbon disease in mice were published on June 13 in PLOS Pathogens. Only a few cases of the newly discovered Bourbon virus have been reported, and two of them ended in death, partly because no specific treatments are available for the tick-borne illness. Now, researchers at Washington University School of Medicine in St. Louis have identified an experimental antiviral drug, often used to treat the flu, that cures mice infected with the potentially lethal virus.  Discuss
UK Scientists Weigh In on Brexit and Laboratory Spending - Science Advisory Board Insights
The long road to a resolution of the Brexit situation appeared to be nearing an end earlier this year, with the deadline set for March 29 to finalize how Britain would exit the EU. A “hard” Brexit, the case if no EU-Britain agreement is reached, would remove Britain from the EU’s single market among other consequences. A “soft” exit would result in Britain remaining part of the single market, but not an EU member. With a government stalemate in Britain, the EU agreed to extend the deadline until October 31, though a deal may come sooner.  Discuss
The Intersection of Life Scientists and Social Media: A Revolution
How do your peers receive information online and how do they utilize social media as a means of learning new information and sharing content? These are just a few of the questions that our colleagues at BioInformatics Inc. explored in a recent report about digital marketing to life scientists.  Discuss
AACR 2019: Sessions Detail Advances in Liquid Biopsies, Machine Learning and Technology Transfer
This year, AACR took place in Atlanta, Georgia, at the Georgia World Congress Center from March 29 to April 3. The conference brought together 21,000 scientists and life science professionals, and 533 exhibiting companies. Sessions not only covered the newest clinical and translational research, but also how AI and machine learning are improving our ability to understand what we already know on a genomic level. Organizations such as the NCI presented on topics including policy, technology transfer and the benefits of private-public partnerships.  Discuss
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter